Marvin Edeas Inventions, Patents and Patent Applications - Justia Patents Search

Marvin Edeas Inventions, Patents and Patent Applications - Justia Patents Search

In the Department of Internal Medicine at Pitié Salpêtrière, he concentrated on gastrointestinal disease. Marvin Edeas ( taught from 2004 to 2013 at the Paris Bobigny and Poitiers Universities. At Paris-Descartes University, Marvin Edeas followed a curriculum on infectious diseases.

Chair of the International Society (ISANH) and the French Society of Antioxidants (SFA) and Founder of the World Mitochondria Society (WMS)

He also chairs the ISANH (International Society of Antioxidants in Nutrition & Health), launched in the year 1998 by Marvin Edeas. He, ISANH and the SFA aim to transfer basic research to real-world applications whether clinical or cosmetic. The established French Society of Antioxidants is a society which Marvin Edeas chairs.

Oysters and Peptides Derived from Hydrolysates Modulate Oxidative Stress

The patents of Marvin Edeas tied into the usage of an oyster enzyme hydrolyzate within a composition that eradicates free radicals and modulates oxidative stress. A start-up was founded in order to market the new peptide due to these patents. Marvin Edeas was successful in determining two Nrf-2 modulators separated from proteins and peptides, which can stimulate the antioxidant defence system. Medicine, cosmetology and dietetics could all gain advantages from Oyster hydrolyzate.

Marvin Edeas collaborates with the National Center for Science in Krakow (Poland), the Agency of Biomedicine and the Agency for the Evaluation of Research and Higher Education. The Chair of the International Society of Antioxidants quite logically handles his annual congress, Paris Redox. Marvin Edeas chairs the worldwide conference Targeting Microbiota and Mitochondria.

The latency mechanisms of HIV in HIV-positive patients, on top of the activation factors, is a field which he devoted six years to researching at the Antoine Béclère Hospital. The factors which cause blastogenic plasma in HIV Type 1 cases were revealed by Marvin Edeas in 1997. He was recognised by Sidaction for his work on HIV. Significant research was carried out on the AIDS virus by Marvin Edeas in the nineties.

Marvin Edeas works with Paris Descartes University, INSERM and CNRS in the Department responsible for Development, Reproduction, Cancer. He chaired the Scientific Committee of the 2016 Targeting Microbiota and Mitochondria Congress, which brought over 400 people together. He joined a team in charge of inflammation, oxidative stress and cell proliferation. Marvin Edeas has been participating as a professor (visiting) at the Cochin Institute, Paris Descartes University, since 2016.